The forecast for China's 10% top-cited scientific publications in Pharmacy shows a dynamic upward trend from 2024 to 2028. Starting at 13.56 publications in 2024 and projected to reach 23.16 by 2028, this trajectory represents significant growth. Year-on-year increase reveals a steady rise of approximately 17% to 18% annually, highlighting a robust growth pattern. The Compound Annual Growth Rate (CAGR) over these five years is indicative of strong momentum within the sector.
Future trends to watch for include technological advancements in pharmaceutical research, potential governmental policy shifts to further boost research outputs, and collaborations with international research bodies that could accelerate China's impact in global scientific communities.
